From: The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya
Malaria severity | Antimalarial drugs | Other drugs (non-anti-malarial) | Average length of stay | Other treatments |
---|---|---|---|---|
Ghana | ||||
UM | Artesunate-amodiaquine (80%); artemether-lumefantrine (20%) | Paracetamol (100%); promethazine (20%) | 0 | - |
MO | Quinine (100%) | Paracetamol (100%); phenobarbital (10%) | 7 | - |
MO + SA | Quinine (100%) | Gentamicin (10%); cotrimoxazole (10%) | 10 | Iron supplementation (100%); blood transfusion (50%) |
CerM | Quinine (80%); artemether lumefantrine (20%) | Paracetamol (80%); hydrocortison (5%); phenobarbital (50%) | 7 | Â |
CerM + NS | Quinine (80%); artemether lumefantrine (20%) | Paracetamol (80%); hydrocortison (5%); phenobarbital (50%) | 12 | Rehabilitation visit every 10 days for 1 year |
Tanzania | ||||
UM | Artesunate-Amodiaquine (75%); Quinine (25%) | Paracetamol (100%); promethazine (20%) | 0 | - |
MO | Quinine (100%) | Paracetamol (100%) | 7 | - |
MO + SA | Quinine (100%) | Gentamicin (10%); cotrimoxazole (10%) | 7 | Iron supplementation (100%); blood transfusion (50%) |
CerM | Quinine (100%) | Paracetamol (60%); phenobarbital (30%) | 7 | Â |
CerM + NS | Quinine (100%) | Paracetamol (60%); phenobarbital (30%) | 10 | Rehabilitation visit every 15 days for 1 year |
Kenya | ||||
UM | Artesunate-amodiaquine (75%); artemether-lumefantrine (25%) | Paracetamol (100%); promethazine (20%) | 0 | - |
MO | Quinine (80%); artemether lumefantrine (20%) | Paracetamol (100%); phenobarbital (10%) | 7 | - |
MO + SA | Quinine (80%); artemether lumefantrine (20%) | Gentamicin (10%); cotrimoxazole (10%) | 9 | Iron supplementation (100%); blood transfusion (50%) |
CerM | Quinine (80%); artemether lumefantrine (20%) | Paracetamol (70%); phenobarbital (30%) | 7 | Â |
CerM + NS | Quinine (80%); artemether lumefantrine (20%) | Paracetamol (70%); hydrocortison (5%); phenobarbital (30%) | 10 | Rehabilitation visit every 15 days for 1 year |